Intracellular lipid accumulation and shift during diabetes progression

Wien Med Wochenschr. 2014 Aug;164(15-16):320-9. doi: 10.1007/s10354-014-0292-y. Epub 2014 Jul 22.

Abstract

In past decades, type 2 diabetes mellitus (T2DM) and nonalcoholic fatty liver disease developed into a global public health disease with an endemic scale. Although up to now the pathogenesis of T2DM is still poorly understood, ectopic lipid accumulation is one of the strongest predictors for T2DM and is closely associated with insulin resistance.This review aims (i) to overview recent literature on the impact of intracellular lipid deposition, (ii) to point out changes in ectopic fat accumulation during diabetes progression or shortly after initializing individual therapy, and finally (iii) to expose unsolved questions and future perspectives in the role of ectopic lipids for the development of insulin resistance and T2DM.

Publication types

  • Review

MeSH terms

  • Blood Glucose / metabolism
  • Comorbidity
  • Diabetes Mellitus, Type 2 / diagnosis*
  • Diabetes Mellitus, Type 2 / physiopathology
  • Diabetes Mellitus, Type 2 / therapy
  • Diabetic Cardiomyopathies / diagnosis
  • Diabetic Cardiomyopathies / physiopathology
  • Diabetic Cardiomyopathies / therapy
  • Disease Progression
  • Fatty Acids, Nonesterified / blood
  • Humans
  • Insulin Resistance / physiology
  • Non-alcoholic Fatty Liver Disease / diagnosis*
  • Non-alcoholic Fatty Liver Disease / physiopathology
  • Non-alcoholic Fatty Liver Disease / therapy
  • Ventricular Dysfunction, Left / diagnosis
  • Ventricular Dysfunction, Left / physiopathology
  • Ventricular Dysfunction, Left / therapy

Substances

  • Blood Glucose
  • Fatty Acids, Nonesterified